Pfizer
PFE
PFE
2,917 hedge funds and large institutions have $131B invested in Pfizer in 2023 Q3 according to their latest regulatory filings, with 126 funds opening new positions, 1,182 increasing their positions, 1,381 reducing their positions, and 207 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $145B → $131B (-$14.2B)
14% less repeat investments, than reductions
Existing positions increased: 1,182 | Existing positions reduced: 1,381
39% less first-time investments, than exits
New positions opened: 126 | Existing positions closed: 207
Holders
2,917
Holding in Top 10
52
Calls
$2.44B
Puts
$2.65B
Top Buyers
| 1 | +$581M | |
| 2 | +$332M | |
| 3 | +$287M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$251M |
| 5 |
D.E. Shaw & Co
New York
|
+$236M |
Top Sellers
| 1 | -$595M | |
| 2 | -$414M | |
| 3 | -$354M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$263M |
| 5 |
BlackRock
New York
|
-$220M |